CareFusion, Baxter Lead $5 Billion Infusion Therapy/Pump Market Driven by Home-Care and Antimicrobial Products

Tuesday, May 17, 2011 General News J E 4

Nation-Wide Infusion Pump Product Recalls Intensifies Market Competition

VANCOUVER, May 17 /PRNewswire/ - According to a new report by iData Research (, the leading global authority in medical device market research, the U.S. infusion therapy device market will exceed $5 billion in 2010, which include needleless connectors, infusion pumps and intravenous (IV) sets. By 2017, the market is estimated to reach over $6.6 billion fueled by the rising use of infusion pumps in alternate and home-care settings, as well as the introduction of smart pumps which utilize electronic medical record data for automated drug dosage monitoring. Growth in this market will also be driven by the increased use of antimicrobial mechanical valve needleless connectors for the reduction of catheter-related bloodstream infections (CRBSIs).

"Medicare and major insurance companies are no longer reimbursing for vascular access associated infections," says Dr. Kamran Zamanian, CEO of iData. "Facilities must absorb the costs of treating such patients and as a result, hospitals are purchasing premium-priced antimicrobial needleless connectors making this segment the fastest-growing in the market with almost 70% growth in 2010. This market is dominated by Baxter's first-to-market V-LinkŪ Luer Activated Device, however ICU Medical and B. Braun are expected to gain market share over the forecast period."

In addition, the report states that due to budgetary constraints, hospitals and private clinics are purchasing less-expensive disposable infusion pumps, boosting sales in the single-use ambulatory infusion pump market. Ambulatory and syringe infusion pumps is also growing at strong rates due to increasing use in the home-care and alternate clinical settings. However, nation-wide product recalls have limited market potential and intensified competition among top manufacturers such as CareFusion, Baxter, Hospira, I-Flow, Moog and Smiths Medical. It has also opened up opportunities for new companies to enter and new technologies to be introduced and gain dominance.

iData's report on "The U.S. Market for Infusion Therapy Devices 2011" includes the latest data, market-analyses and competitor profiles for over 17 segments.

For more information, register free on iData's website at:

About iData Research

iData Research ( is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: vascular access, interventional cardiology, peripheral vascular, cardiac surgery and more.

SOURCE iData Research Inc.



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
eCardio Diagnostics Announces Three Executive Appo...
Project to Harmonize Health Research Guidelines An...